Drawing for TICEBA

USPTO serial 79215539

TICEBA

Reviewed by CopyMark Law Group

Reg. 5516119Status 404
Filing date
Status date
Registration date
Jul 17, 2018
Examiner
BATT, JAIME L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TICEBA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia W. Stangle

Schreiberstraße 20C/O MILLER Rechtsanwälte79098 FREIBURG,

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treatment of skin diseases; pharmaceutical preparations for the treatment of vertigo; pharmaceutical preparations for treatment of nausea; pharmaceutical preparations for treatment of vomiting; pharmaceutical preparations for treatment of migraine; pharmaceutical preparations for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, the urinary system, the integumentary system, and the reproductive system; pharmaceutical preparations for treatment of blood diseases and disorders; pharmaceutical preparations, namely, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; pharmaceutical preparations for wound healing; pharmaceutical preparations for anti-aging, namely, stem cells for medical and aesthetic purposes, fibroblasts for medical and aesthetic purposes, surgical tissue implants obtained from stem cells, surgical tissue implants obtained from fibroblastsSECTION 71 - CANCELLED—
039Packaging, storage and transport of human tissue and human adult ancestral cellsSECTION 71 - CANCELLED—
044Medical services in the area of regenerative medicine and tissue-engineeringSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
May 7, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 4, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 4, 2026INPCINVALIDATION PROCESSED—
Sep 30, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 31, 2025C71TCANCELLED SECTION 71—
Nov 16, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 29, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 29, 2018FIMPFINAL DISPOSITION PROCESSED—
Oct 17, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 17, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 1, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 11, 2018NPUBNOTICE OF PUBLICATION—
Mar 26, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2018DMCCDATA MODIFICATION COMPLETED—
Mar 23, 2018ALIEASSIGNED TO LIE—
Mar 16, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 15, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 15, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 24, 2017RFNTREFUSAL PROCESSED BY IB—
Nov 6, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 6, 2017RFRRREFUSAL PROCESSED BY MPU—
Oct 31, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 30, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2017DOCKASSIGNED TO EXAMINER—
Sep 12, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 31, 2017SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance